Skip to content
10-Q

Quarterly Report

BIOADAPTIVES, INC. BDPT

0001640334-24-000843

← back to feed
Filed
May 17, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 17, 2024 1.17B sh
Current Liabilities Q1 2024 · Mar 31, 2024 $1.86M
Current Liabilities Q1 2024 · Dec 31, 2023 $1.75M
Total Liabilities Q1 2024 · Mar 31, 2024 $1.86M
Total Liabilities Q1 2024 · Dec 31, 2023 $1.75M
Current Assets Q1 2024 · Mar 31, 2024 $40.67K
Current Assets Q1 2024 · Dec 31, 2023 $88.56K
Total Assets Q1 2024 · Mar 31, 2024 $58.67K
Total Assets Q1 2024 · Dec 31, 2023 $104K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$19.46K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$1.63M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$1.45M
Sga Expense Q1 2024 · Mar 31, 2023 $12.04K
Net Income Q1 2024 · Mar 31, 2023 −$287.19K
Operating Income Q1 2024 · Mar 31, 2023 −$18.98K
Gross Profit Q1 2024 · Mar 31, 2023 $1.98K
Cost Of Revenue Q1 2024 · Mar 31, 2023 $1.4K
Revenue Q1 2024 · Mar 31, 2023 $3.38K